Kontour Medical's net profit in 2024 is 88.5708 million yuan, an increase of 17.3%
Kontour Medical released its 2024 performance preliminary report, with operating revenue reaching 322 million yuan, a year-on-year increase of 17.06%; net profit was 88.5708 million yuan, a year-on-year increase of 17.30%. The net profit after deducting non-recurring gains and losses was 75.0325 million yuan, an increase of 9.77%. The basic earnings per share were 1.09 yuan. The company expects that as the centralized procurement in neurosurgery progresses, the growth rate of net profit will remain consistent with the growth rate of revenue
According to the Zhitong Finance APP, Kontour Medical (688314.SH) disclosed its 2024 annual performance preliminary report, showing an operating revenue of 322 million yuan, a year-on-year increase of 17.06%; a net profit attributable to the parent company's owners of 88.5708 million yuan, a year-on-year increase of 17.30%; and a net profit attributable to the parent company's owners after deducting non-recurring gains and losses of 75.0325 million yuan, a year-on-year increase of 9.77%. The basic earnings per share is 1.09 yuan.
The announcement indicates that as the inter-provincial alliance neurosurgery centralized procurement in Henan Province gradually takes effect in 2024, the company is accelerating the admission of neurosurgery products and expanding coverage in lower-tier markets, promoting the penetration rate of PEEK material products. The net profit growth rate for 2024 is expected to be roughly in line with the revenue growth rate
